In situ fluorescence analysis demonstrates active siRNA exclusion from the nucleus by Exportin 5

Institute for Biophysics, BIOTEC, Dresden University of Technology, Tatzberg 47-51, 01307 Dresden, Germany.
Nucleic Acids Research (Impact Factor: 9.11). 02/2006; 34(5):1369-80. DOI: 10.1093/nar/gkl001
Source: PubMed


Two types of short double-stranded RNA molecules, namely microRNAs (miRNAs) and short interfering RNAs (siRNAs), have emerged recently as important regulators of gene expression. Although these molecules show similar sizes and structural features, the mechanisms of action underlying their respective target silencing activities appear to differ: siRNAs act primarily through mRNA degradation, whereas most miRNAs appear to act primarily through translational inhibition. Our understanding of how these overlapping pathways are differentially regulated within the cell remains incomplete. In the present work, quantitative fluorescence microscopy was used to study how siRNAs are processed within human cells. We found that siRNAs are excluded from non-nucleolar areas of the nucleus in an Exportin-5 dependent process that specifically recognizes key structural features shared by these and other small RNAs such as miRNAs. We further established that the Exportin-5-based exclusion of siRNAs from the nucleus can, when Exp5 itself is inhibited, become a rate-limiting step for siRNA-induced silencing activity. Exportin 5 therefore represents a key point of intersection between the siRNA and miRNA pathways, and, as such, is of fundamental importance for the design and interpretation of RNA interference experimentation.

Download full-text


Available from: Petra Schwille, Oct 08, 2014
21 Reads
  • Source
    • "Drosha is responsible for recognizing and polishing primiRNAs by cleaving it with special structure. This binding is called a conserved structural functionality since no conserved sequences are found on pre-miRNA for Drosha (Ohrt et al. 2006). Furthermore, Drosha binds and cleaves various primiRNAs in different efficiencies and specificities. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Understanding gene regulation mechanisms has been a serious challenge in biology. As a novel mechanism, small non-coding RNAs are an alternative means of gene regulation in a specific and efficient manner. There are growing reports on regulatory roles of these RNAs including transcriptional gene silencing/activation and post-transcriptional gene silencing events. Also, there are several known small non-coding RNAs which all work through RNA interference pathway. Interestingly, these small RNAs are secreted from cells toward targeted cells presenting new communication approach in cell-cell or cell-organ signal transduction. In fact, understanding cellular and molecular basis of these pathways will strongly improve developing targeted therapies and potent and specific regulatory tools. This study will review some of the most recent findings in this subject and will introduce a super-pathway RNA interference-based small RNA silencing network.
    Functional & Integrative Genomics 11/2013; 14(1). DOI:10.1007/s10142-013-0344-1 · 2.48 Impact Factor
  • Source
    • "This implied that one or a few components of the RNAi pathway, which are engaged by si, sh and miRNAs, are rate-limiting and thus titratable (4,13–15). To narrow down these factors, we and others inhibited or overexpressed different proteins involved in RNAi and characterized the effects on co-delivered si or shRNAs in vitro and in vivo (3,10,11,16–20). One of the hits was Exportin-5, the karyopherin shuttling mi and shRNA precursors from the nucleus to the cytoplasm (3,18–21). "
    [Show abstract] [Hide abstract]
    ABSTRACT: As the only mammalian Argonaute protein capable of directly cleaving mRNAs in a small RNA-guided manner, Argonaute-2 (Ago2) is a keyplayer in RNA interference (RNAi) silencing via small interfering (si) or short hairpin (sh) RNAs. It is also a rate-limiting factor whose saturation by si/shRNAs limits RNAi efficiency and causes numerous adverse side effects. Here, we report a set of versatile tools and widely applicable strategies for transient or stable Ago2 co-expression, which overcome these concerns. Specifically, we engineered plasmids and viral vectors to co-encode a codon-optimized human Ago2 cDNA along with custom shRNAs. Furthermore, we stably integrated this Ago2 cDNA into a panel of standard human cell lines via plasmid transfection or lentiviral transduction. Using various endo- or exogenous targets, we demonstrate the potential of all three strategies to boost mRNA silencing efficiencies in cell culture by up to 10-fold, and to facilitate combinatorial knockdowns. Importantly, these robust improvements were reflected by augmented RNAi phenotypes and accompanied by reduced off-targeting effects. We moreover show that Ago2/shRNA-co-encoding vectors can enhance and prolong transgene silencing in livers of adult mice, while concurrently alleviating hepatotoxicity. Our customizable reagents and avenues should broadly improve future in vitro and in vivo RNAi experiments in mammalian systems.
    Nucleic Acids Research 09/2013; 41(21). DOI:10.1093/nar/gkt836 · 9.11 Impact Factor
  • Source
    • "Depletion of CLIMP-63 protein levels in 293T-REx cells was not associated with a concomitant decrease in the level of let-7, miR-17 and miR-21 microRNAs (our unpublished data), suggesting that the effects on RNA silencing may be related to changes in the function, rather than the level, of endogenous microRNAs. However, the caveats have to be taken into account that: (i) the cells that were the most depleted in CLIMP-63, and thus most likely to exhibit a phenotype, may not have survived and been included in our analyses; (ii) changes in the level, activity or function of protein and RNA components of the microRNA pathway other than Exportin-5, which is considered as the rate-limiting step in microRNA biogenesis in human cells (33), need to fall below that threshold to be detected, a situation that may not be achieved upon incomplete CLIMP-63 depletion and (iii) the pool of Dicer proteins affected upon knockdown of CLIMP-63 may not be involved in microRNA biogenesis and may function instead as part of the microRNA effector complex, independently of microRNA levels. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The ribonuclease Dicer plays a central role in the microRNA pathway by catalyzing the formation of microRNAs, which are known to regulate messenger RNA (mRNA) translation. In order to improve our understanding of the molecular context in which Dicer functions and how it is regulated in human cells, we sought to expand its protein interaction network by employing a yeast two-hybrid screening strategy. This approach led to the identification and characterization of cytoskeleton-linking endoplasmic reticulum (ER) membrane protein of 63 kDa (CLIMP-63) as a novel Dicer-interacting protein. CLIMP-63 interacts with Dicer to form a high molecular weight complex, which is electrostatic in nature, is not mediated by RNA and is catalytically active in pre-microRNA processing. CLIMP-63 is required for stabilizing Dicer protein and for optimal regulation of a reporter gene coupled to the 3' untranslated region of HMGA2 mRNA in human cells. Interacting with a portion of the luminal domain of CLIMP-63 and within minutes of its synthesis, our results suggest that Dicer transits through the ER, is glycosylated and can be secreted by cultured human cells with CLIMP-63. Our findings define CLIMP-63 as a novel protein interactor and regulator of Dicer function, involved in maintaining Dicer protein levels in human cells.
    Nucleic Acids Research 10/2012; 40(22). DOI:10.1093/nar/gks903 · 9.11 Impact Factor
Show more